August 2014 has been a great month for people with neurological illnesses, as they finally saw their type of illness broadcast, and indeed, doused by ALS ice bucket challenges.
To quickly place ALS amongst other neurological illnesses, perhaps the most famous person with ALS is Stephen Hawking, a personal hero of mine since my teenage years. ALS, also called MND (Motor Neurone Disease and Lou Gehrig’s Disease), is similar to multiple sclerosis and has several causes. A lot of money has gone to charitable organisations supporting ALS as well as other neurological illnesses.
In short: finally, attention is on people living with a neurodegenerative (in other words: progressive) illness. The bucket challenge, my blog and many others, is just a tiny bit of proof of life with a progressive illness..
- Multiple Sclerosis and Osteoporosis: What’s the Connection?
Healthline – At first glance, multiple sclerosis (MS) and osteoporosis appear to be two very different diseases. One attacks the nerves and the other the bones. But dig a little deeper and it’s clear they have a lot in common.
- Natural Multiple Sclerosis Treatment Review Reveals the Inside Story to Gary M. Levin’s Cure …
DigitalJournal.com – The Natural Multiple Sclerosis Treatment review recently published by Daily Gossip reveals the inside story to Gary M. Levin’s cure program.
- Nanotechnology a Possible Future Solution for Multiple Sclerosis
HCPLive – A University of Southern California (USC) PhD student has announced plans to develop a model of a human brain that can mimic the electrical circuit pathways of multiple sclerosis (MS) and other neurological diseases that can affect patients.
- MS and Sex
Huffington Post – Before an MS award dinner last week, I sat down with nine guys from the Mandell Center for Multiple Sclerosis in Hartford. Mandell deals with urological issues related to MS. This is the only program of its kind in the country. These guys were a support group.
- Experts say new hope for those with M-S, as transplants might be the key to the future
KCBD-TV – Six months ago, he had a stem cell transplant, and now, a new treatment is giving Dan and other patients with multiple sclerosis a whole new outlook.
- HIV May Protect Against Multiple Sclerosis
Medscape – New research supports an association between HIV infection and a reduced risk for multiple sclerosis (MS). Investigators at the Prince of Wales
- Yale scientists track origins of multiple sclerosis
HealthCanal.com – Research in the News: Yale scientists track origins of multiple sclerosis, an autoimmune response that is involved in multiple sclerosis (MS) was once thought to be confined to the brain.
- No Link Between Vitamin D Levels in Newborns and Multiple Sclerosis
Science World Report – Multiple sclerosis (MS) is one of the most disabling neurological diseases that affect 250,000-350,000 people in the U.S.
- Gene that controls nerve conduction velocity linked to multiple sclerosis
EurekAlert (press release) – Investigators report that even minor reductions in conduction velocity may aggravate disease in multiple sclerosis (MS) patients and in mice bred for the MS-like condition experimental autoimmune encephalomyelitis (EAE).
- Multiple Sclerosis Symptoms Aggravated By Genetic Alterations in Patients
Multiple Sclerosis News Today – genetic alteration in MS While the majority of scientists dedicated to multiple sclerosis research focus on genetic regulators of conditions such as autoimmunity, demyelination, inflammation, and neurodegeneration, a team from the University of Lubeck in Germany, led by Saleh M. Ibrahim, MD, PhD, focuses on genetic regulators of conduction velocity.
- Everyday Health Examines Link Between Heat and Multiple Sclerosis
MarketWatch – Everyday Health, the leading digital health and wellness company, examines the link between heat and multiple sclerosis (MS).
- Researchers Find MS Drug Fingolimod Decreases Gd-enhancing Lesions
Multiple Sclerosis News Today – fingolimod and RRMS Fingolimod is a disease-modifying therapy (DMT) used to treat relapsing-remitting multiple sclerosis (RRMS) patients as well as patients who continue to present with relapses despite treatment with beta interferon drugs.
- Expanded Data on Disability and Cognitive Improvements in Phase II Study of Synthetic Biologics …
MarketWatch – The data will be presented at the 2014 Joint Americas and European Committees for Treatment and Research in Multiple Sclerosis Meeting
- Research and Markets: Relapsing Multiple Sclerosis (RMS) Global Clinical Trials Review, H2, 2014
DigitalJournal.com – Our clinical trial report, Relapsing Multiple Sclerosis (RMS) Global Clinical Trials Review, H2, 2014″ provides data on the Relapsing Multiple Sclerosis.
- Data From Multiple Sclerosis Study of Trimesta For Disability, Cognitive Improvements in Women …
Multiple Sclerosis News Today – Multiple Sclerosis, an immune-mediated disease whereby progressive neurological degeneration leads to pain, loss of muscle control, paralysis.
- 90 Secondary Progressive MS Patients To Be Recruited To Test Novel Experimental Therapy
Multiple Sclerosis News Today – It has begun to recruit patients with Secondary Progressive Multiple Sclerosis (SPMS) for its phase 2B trial of its experimental therapy MIS416.
Medical treatment news
- NYSCF Scientists Closer to Developing Cell Replacement Therapy For Multiple Sclerosis Patients
Multiple Sclerosis News Today – Since multiple sclerosis is a chronic demyelinating disease of unknown etiology that affects the central nervous system, with current therapies primarily directed to work against the immune system.
- Complementary and Alternative Medicine is Gaining Credibility Among MS Patients
Multiple Sclerosis News Today – Complementary and alternative medicine (CAM) are no substitutes for the regular treatment of multiple sclerosis (MS).
- FDA approves Biogen’s multiple sclerosis drug
wwlp.com – Multiple sclerosis is a disease of the immune system in which the body attacks the brain and spinal cord. Its symptoms can come and go, often reappearing months later.
- New Treatment for Multiple Sclerosis Can Be Expected
TWC News – More than 3.5 million people worldwide have multiple sclerosis. Most of these people are found in the United States; it affects women in their prime.
- Anti-psychotic drugs to be used in Multiple Sclerosis study
TVNZ – New Zealand researchers have been given the green light to trial new treatments on multiple sclerosis patients using anti-psychotic drugs.
- Cannabis-based medicine for multiple sclerosis patients will be available on the NHS in Wales
Daily Mail – A cannabis-based drug designed to alleviate the symptoms of multiple sclerosis is to be made available on prescription in Wales.
- Cleveland Clinic app helps assess multiple sclerosis symptoms
iMedicalApps – Neuroscientists at the Cleveland Clinic have developed an iPad-based tool for assessing disability and symptoms from multiple sclerosis.
- Big Multiple Sclerosis Conference Scheduled For September in Boston
Multiple Sclerosis News Today – President of the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS), Suhayl Dhib-Jalbut, publicly announced the details of this year’s MSBoston2014 conference, in collaboration with the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS).
- Regulus Enters Into New Collaboration Agreement with Biogen Idec to Identify microRNA …
MarketWatch – “Our collaboration has made significant progress to date and we are hopeful to continue to help advance Biogen Idec’s leading multiple sclerosis the discovery and development of innovative medicines.
- Global Market for Multiple Sclerosis Disease-Modifying Products to Reach Nearly $142 Billion by …
IT Business Net – MULTIPLE SCLEROSIS (MS) DRUGS AND BIOLOGICS: TECHNOLOGIES AND GLOBAL MARKETS, the global market for multiple sclerosis (MS) disease-modifying products reached nearly $10.9 billion in 2013.
- 5 companies that will get a boost from Ice Bucket Challenge
New York Post – Biogen’s second-quarter profit blew past expectations in July due to demand for its multiple sclerosis treatments. Its shares are up 12.5 percent over the last month and 22 percent since January.
© Willeke Van Eeckhoutte and Ireland, Multiple Sclerosis & Me, 2011-2014. Unauthorised use and/or duplication of this material without express and written permission from this blog’s author and/or owner are strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Willeke Van Eeckhoutte and Ireland, Multiple Sclerosis & Me with appropriate and specific direction to the original content.